JP2004521897A - 経口イトラコナゾール調製物およびその製造法 - Google Patents

経口イトラコナゾール調製物およびその製造法 Download PDF

Info

Publication number
JP2004521897A
JP2004521897A JP2002562325A JP2002562325A JP2004521897A JP 2004521897 A JP2004521897 A JP 2004521897A JP 2002562325 A JP2002562325 A JP 2002562325A JP 2002562325 A JP2002562325 A JP 2002562325A JP 2004521897 A JP2004521897 A JP 2004521897A
Authority
JP
Japan
Prior art keywords
itraconazole
particles
dosage form
particle
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002562325A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004521897A5 (enExample
Inventor
ランガ， ラジュ ナンブリ，
ジョン， エルギン ケル，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2004521897A publication Critical patent/JP2004521897A/ja
Publication of JP2004521897A5 publication Critical patent/JP2004521897A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2002562325A 2001-02-06 2002-02-01 経口イトラコナゾール調製物およびその製造法 Pending JP2004521897A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26665301P 2001-02-06 2001-02-06
US09/933,032 US6663897B2 (en) 2001-02-06 2001-08-20 Oral itraconazole formulations and methods of making the same
PCT/NL2002/000080 WO2002062318A2 (en) 2001-02-06 2002-02-01 Oral itraconazole formulations and methods of making the same

Publications (2)

Publication Number Publication Date
JP2004521897A true JP2004521897A (ja) 2004-07-22
JP2004521897A5 JP2004521897A5 (enExample) 2005-12-22

Family

ID=26951964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002562325A Pending JP2004521897A (ja) 2001-02-06 2002-02-01 経口イトラコナゾール調製物およびその製造法

Country Status (9)

Country Link
US (1) US6663897B2 (enExample)
EP (1) EP1357899B1 (enExample)
JP (1) JP2004521897A (enExample)
AT (1) ATE369840T1 (enExample)
AU (1) AU2002233822A1 (enExample)
CA (1) CA2437372A1 (enExample)
DE (1) DE60221795T2 (enExample)
MX (1) MXPA03006980A (enExample)
WO (1) WO2002062318A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
US7446107B2 (en) 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
WO2003101392A2 (en) 2002-05-31 2003-12-11 Transform Pharmaceuticals, Inc. Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2004000284A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
WO2004012714A1 (en) * 2002-08-05 2004-02-12 Dsm Ip Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IT1263831B (it) 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
SK177598A3 (en) * 1996-06-28 1999-07-12 Schering Corp Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
ID21477A (id) * 1997-03-26 1999-06-17 Janssen Pharmaceutica Nv Pelet-pelet yang mempunyai inti yang dilapisi dengan suatu anti jamur dan suatu polimer
WO2000003697A1 (en) * 1998-07-17 2000-01-27 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
ATE307808T1 (de) 1999-03-24 2005-11-15 Scherer Technologies Inc R P Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
EP1357899A2 (en) 2003-11-05
US20020150620A1 (en) 2002-10-17
DE60221795T2 (de) 2007-12-27
CA2437372A1 (en) 2002-08-15
WO2002062318A3 (en) 2002-11-21
MXPA03006980A (es) 2004-10-15
DE60221795D1 (de) 2007-09-27
AU2002233822A1 (en) 2002-08-19
ATE369840T1 (de) 2007-09-15
WO2002062318A2 (en) 2002-08-15
EP1357899B1 (en) 2007-08-15
US6663897B2 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
EP1667660B1 (en) Pantoprazole multiparticulate formulations
EP1513535B1 (en) Controlled release formulation of lamotrigine
EP1976492B1 (en) Drug delivery systems comprising weakly basic drugs and organic acids
AU734248B2 (en) Pellets having a core coated with an antifungal and a polymer
EP4623907A2 (en) Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
JP2004521897A (ja) 経口イトラコナゾール調製物およびその製造法
KR20030079766A (ko) 항진균 포뮬레이션, 그의 제조 방법 및 사용 방법
RU2647472C2 (ru) Фармацевтическая композиция омепразола
US20150140089A1 (en) Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity
US8071133B2 (en) Oral dosage forms of water insoluble drugs and methods of making the same
WO2007102714A1 (en) Safe controlled release preparation composition containing zolpidem or its salt
WO2022074681A1 (en) Pharmaceutical compositions with enhanced blend uniformity and content uniformity
EP2046303A1 (en) Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
WO2011018801A2 (en) Solid oral dosage form of ziprasidone
EP1539111A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) Oral itraconazole formulations and methods of making the same
EP1842532A2 (en) Oral sparingly water-soluble antifungal formulations and methods of making the same
JP2005298472A (ja) イトラコナゾールを含む経口投与用組成物
US20070148240A1 (en) Oral formulation containing itraconazole and methods for manufacturing and using the same
HK1086766B (en) Pantoprazole multiparticulate formulations
WO2008126098A1 (en) Extended release pharmaceutical formulation of propranolol hydrochloride
MX2008009613A (en) Drug delivery systems comprising weakly basic drugs and organic acids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050201

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050201

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20060721

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20060901

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080902

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090217